Description

Butanoic Acid, 4-[[[1-Oxo-16-(2H-Tetrazol-5-Yl)Hexadecyl]Amino]Sulfonyl]- is a specialized synthetic organic compound featuring a unique molecular architecture that combines a butanoic acid core with a tetrazole-containing sulfonamide side chain. This structure matters for its potential as a high-value pharmaceutical intermediate or biochemical research tool, particularly in the development of enzyme inhibitors or receptor-targeting agents. It is primarily needed by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and advanced materials sectors seeking novel molecular entities for drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), especially those targeting metabolic or inflammatory pathways.
• Biochemical Research: Used as a potential ligand or probe in enzymatic studies and receptor binding assays due to its sulfonamide and tetrazole functional groups.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to develop new drug candidates with optimized potency and selectivity.
• Specialty Chemical Synthesis: Acts as a precursor for creating more complex molecules with specific biological or material properties.
• Protease Inhibitor Development: The sulfonamide moiety makes it a candidate scaffold for designing inhibitors of proteolytic enzymes.

Basic Information

Product Name	Butanoic Acid, 4-[[[1-Oxo-16-(2H-Tetrazol-5-Yl)Hexadecyl]Amino]Sulfonyl]-
CAS No.	873874-16-9
Molecular Formula	C₂₁H₃₉N₅O₅S
Molecular Weight	481.63 g/mol
Synonyms	4-[[[1-Oxo-16-(2H-tetrazol-5-yl)hexadecyl]amino]sulfonyl]butanoic acid; 4-({[1-Oxo-16-(1H-tetrazol-5-yl)hexadecyl]amino}sulfonyl)butanoic acid; 873874-16-9; Butanoic acid, 4-[[[1-oxo-16-(2H-tetrazol-5-yl)hexadecyl]amino]sulfonyl]-; 4-({[1-Oxo-16-(2H-tetrazol-5-yl)hexadecyl]amino}sulfonyl)butanoate
EINECS	Contact for details

Quality Control

Our high-purity specialty chemicals are produced under a strict quality management system. Each batch of Butanoic Acid, 4-[[[1-Oxo-16-(2H-Tetrazol-5-Yl)Hexadecyl]Amino]Sulfonyl]- undergoes rigorous analytical testing, including HPLC and NMR, to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment to support your research and development documentation requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to exclude moisture. Keep away from incompatible materials such as strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.